PI3 has also been linked to lung tissue repair and is a candidate biomarker for lung diseases including acute respiratory lung disease and asthma (Wang et al., 2017; Tsai et al., 2016), as well as modulator of inflammation through the inhibition of neutrophil derived elastases (Alam et al., 2012). Here, PI3 is linked to lung disorder.